HUP0004338A2 - Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai - Google Patents

Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai Download PDF

Info

Publication number
HUP0004338A2
HUP0004338A2 HU0004338A HUP0004338A HUP0004338A2 HU P0004338 A2 HUP0004338 A2 HU P0004338A2 HU 0004338 A HU0004338 A HU 0004338A HU P0004338 A HUP0004338 A HU P0004338A HU P0004338 A2 HUP0004338 A2 HU P0004338A2
Authority
HU
Hungary
Prior art keywords
ser
gly
peptide
gin
arg
Prior art date
Application number
HU0004338A
Other languages
English (en)
Hungarian (hu)
Inventor
Lydie Meheus
Joseph Raymackers
Ann Union
Original Assignee
Innogenetics N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98870078A external-priority patent/EP0949270A1/fr
Application filed by Innogenetics N.V. filed Critical Innogenetics N.V.
Publication of HUP0004338A2 publication Critical patent/HUP0004338A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0004338A 1997-11-28 1998-11-30 Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai HUP0004338A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870195 1997-11-28
EP98870078A EP0949270A1 (fr) 1998-04-09 1998-04-09 Peptides synthétiques contenant de la citrulline et reconnus par les sérums de patients souffrant d'arthrite rhumatoide utilisés comme outils de diagnostic et de traitement

Publications (1)

Publication Number Publication Date
HUP0004338A2 true HUP0004338A2 (hu) 2001-02-28

Family

ID=26148315

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004338A HUP0004338A2 (hu) 1997-11-28 1998-11-30 Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai

Country Status (8)

Country Link
EP (1) EP1034186A2 (fr)
JP (1) JP2002512939A (fr)
AU (1) AU2155899A (fr)
CA (1) CA2309534A1 (fr)
CZ (1) CZ20001963A3 (fr)
HU (1) HUP0004338A2 (fr)
PL (1) PL344534A1 (fr)
WO (1) WO1999028344A2 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7184426B2 (en) 2002-12-12 2007-02-27 Qualcomm, Incorporated Method and apparatus for burst pilot for a time division multiplex system
FR2773078B1 (fr) * 1997-12-30 2000-05-26 Univ Toulouse Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
WO2001046222A2 (fr) * 1999-12-21 2001-06-28 Innogenetics N.V. Peptides permettant de diagnostiquer et de traiter la polyarthrite rhumatoide
FR2826124B1 (fr) * 2001-06-13 2004-01-02 Bio Merieux Procede de detection d'auto-anticorps specifiques de la polyarthrite rhumatoide
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
MXPA06001173A (es) * 2003-07-29 2006-04-11 Solvay Pharm Gmbh Metodo analitico para la pancreatina y composiciones comparables.
AT413768B (de) * 2003-07-29 2006-05-15 Herkner Kurt Dipl Ing Dr Techn Biochemisches diagnostikum zur erkennung rheumatoider arthritis
PT1882946E (pt) 2003-12-23 2010-04-21 Roche Diagnostics Gmbh Método para avaliar artrite reumatóide através da medição de anti-ccp e interleucina 6
SI1721162T1 (sl) 2004-02-27 2009-02-28 Roche Diagnostics Gmbh Postopek za ugotavljanje revmatoidnega artritisa z merjenjem anti-CCP in serumskega amiloida A
BRPI0614914A2 (pt) 2005-07-29 2011-04-19 Solvay Pharm Gmbh processos para a fabricação de pó de pancreatina esterilizada
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
FR2900657B1 (fr) * 2006-05-03 2009-04-17 Univ Toulouse Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2008037420A1 (fr) 2006-09-29 2008-04-03 Roche Diagnostics Gmbh Évaluation du risque de progression de la maladie pour un patient présentant une polyarthrite rhumatoïde
CA2707870C (fr) * 2007-12-03 2015-01-27 Sqi Diagnostics Systems Inc. Peptides synthetiques immunoreactifs avec des auto-anticorps de la polyarthrite rhumatoide
EA023302B9 (ru) * 2008-06-04 2016-10-31 Модиквест Б.В. Способ предотвращения или лечения артрита и применение антитела, специфически реактивного к цитруллинированному эпитопу в этом способе
EP3070097A3 (fr) * 2009-03-30 2016-11-23 Nestec S.A. Peptides citrullines pour le diagnostic et le pronostic de la polyarthrite rhumatoïde
EP2325195A1 (fr) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Peptides à citrulline et utilisations associées
EP2336769A1 (fr) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Test pour différencier les troubles rhumatismaux des troubles non rhumatismaux
EP2402368A1 (fr) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Peptides de citrulline histone et utilisations associées
EP2527841A1 (fr) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Procédés pour le diagnostic de l'arthrite rhumatoïde
EP2715360B1 (fr) * 2011-05-27 2016-08-17 Nordic Bioscience A/S Détection de peptides diagnostiques
KR101656847B1 (ko) * 2011-08-12 2016-09-12 고쿠리츠다이가쿠호진 히로시마다이가쿠 석면 검출 방법
HK1199246A1 (en) 2011-12-16 2015-06-26 奥乐玛药物股份有限公司 Novel benzopyran compounds, compositions and uses thereof
US9975944B2 (en) * 2013-03-12 2018-05-22 Tel Hashomer Medical Research Infrastructure And Services Ltd. Synthetic peptides for the treatment of autoimmune diseases
WO2015010791A2 (fr) 2013-07-24 2015-01-29 Klareskog, Lars Nouveaux anticorps pour le diagnostic et le traitement de la polyarthrite rhumatoïde
KR101634958B1 (ko) * 2014-06-13 2016-06-30 한국생명공학연구원 필라그린 유전자 돌연변이 검출용 프로브, 키트 및 방법
WO2016128348A1 (fr) 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Procédé d'évaluation de la polyarthrite rhumatoïde par mesure des anti-ccp et anti-pik3cd
EP3056903A1 (fr) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Procédé d'évaluation de l'arthrite rhumatoïde par la mesure de l'anti-CCP et de l'anti-Casp8
EP3056904A1 (fr) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Procédé pour l'évaluation de l'arthrite rhumatoïde par la mesure de l'anti-CCP et de l'anti-MCM3
CN111007262A (zh) * 2019-12-25 2020-04-14 漳州卫生职业学院 一种用于辅助诊断ra的试剂盒及检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660994A (en) * 1986-11-10 1997-08-26 Progen Biotechnik Gmbh Method of detecting tissue-specific, insoluble cytoskeletal proteins
DE69233366T2 (de) * 1991-04-26 2005-05-19 Biomerieux S.A. Antigene, die von Polyarthritis Rheumatoide Antikörpern erkannt werden, ihre Herstellung und ihre Anwendungen
FR2752842B1 (fr) * 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.

Also Published As

Publication number Publication date
CA2309534A1 (fr) 1999-06-10
CZ20001963A3 (cs) 2002-04-17
WO1999028344A3 (fr) 1999-08-12
JP2002512939A (ja) 2002-05-08
PL344534A1 (en) 2001-11-05
WO1999028344A2 (fr) 1999-06-10
AU2155899A (en) 1999-06-16
EP1034186A2 (fr) 2000-09-13

Similar Documents

Publication Publication Date Title
HUP0004338A2 (hu) Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai
AU751784B2 (en) Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
PT941244E (pt) Péptido derivados de um antigénio reconhecido por autoanticorpos de pacientes com artrite reumatóide, anticorpo dirigido contra o referido péptido e método de detecção de anticorpos auto-imunes
Yiannaki et al. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods
US20020143143A1 (en) Peptides designed for the diagnosis and treatment of rheumatoid arthritis
CA2331845A1 (fr) Composes et procedes servant a diagnostiquer et a traiter l'infection par ehrlichia
DK2588495T3 (en) Histoncitrullinerede peptides and uses thereof
JP4374316B2 (ja) β−アミロイドまたはその誘導体に対する抗体およびその用途
US5407833A (en) Peptides of the SM-D antigen and their use for diagnosis of systemic lupus erythematosus
EP0949270A1 (fr) Peptides synthétiques contenant de la citrulline et reconnus par les sérums de patients souffrant d'arthrite rhumatoide utilisés comme outils de diagnostic et de traitement
EP1614692A2 (fr) ME-5, ME-2, and EPP2: protéines humaines antigéniques réactives contre des autoanticorps présents dans le serum de femmes atteintes d'endométriose
JPWO1997017441A1 (ja) 自己抗原
WO2006000056A1 (fr) Nouvelles methodes de diagnostic pour le traitement des infections par p. aeruginosa et reactifs pour ces methodes
WO1991015584A1 (fr) Peptides recombinants et synthetiques de trypanosoma cruzi utilises pour le diagnostic immunologique de la maladie de chagas
US20070249531A1 (en) Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
Miura et al. Identification of epitopes for cross-reaction, auto-reaction and autoantibodies to catalase
AU2003267876A1 (en) Aspartyl protease inhibitor as a nematode allergen
JP2006180704A (ja) 新規タンパクおよびその用途
EP1732382A2 (fr) Proteine porteuse d'energie flagellaire du sperme (sfec)
AU2005256177A1 (en) Novel methods of diagnosis of treatment of P. aeruginosa infection and reagents therefor
NZ521434A (en) Novel allergen